Department of Biochemistry and Biophysics
Stockholm University announce a sponsored research agreement with Ipsen
Stockholm University announces that it has initiated a research collaboration on structural studies of novel engineered botulinum toxins with Ipsen, a global specialty driven pharmaceutical group.
Under the terms of the agreement, Ipsen will fund research in the laboratory of Associate Prof. Pål Stenmark at the Department of Biochemistry and Biophysics, Stockholm University, with a focus on structural biology, protein design and the biophysical properties of novel engineered botulinum toxins.
Insight into bacterial cell division
One approach to fight bad bacteria is to better understand how they divide and multiply. In each bacterium, a large protein complex – called the divisome – governs cell division. The divisome assembles in the middle of the cell to divide the cell and later disassembles to recycle the proteins. A group of scientists at Stockholm University, together with collaborators at the Okinawa Institute of Science and Technology Graduate University (OIST) showed for the first time how this big protein complex inside living E. coli cells disassembles after each round of division.
Grants from the European commission to DBB
The European commission has decided to fund an international training network that focusses on the molecular mechanisms of mitochondrial gene expression. Among the fourteen groups from Europe are Alexey Amunts and Martin Ott from DBB.
Piecing together the cells “elevator-like” mechanism for sodium
Researchers from Stockholm University have pieced together how sodium is transported into and out of our cells. This could be a potential benefit for the development of novel treatments against some forms of cancer and hypertension. The results are published as an article in the scientific journal Nature Structure and Molecular Biology.